|
US2917432A
(en)
|
1954-10-05 |
1959-12-15 |
Burroughs Wellcome Co |
Leukemia treatment
|
|
US3046301A
(en)
|
1959-10-29 |
1962-07-24 |
Burroughs Wellcome Co |
Method of making chlorambucil
|
|
GB1354939A
(en)
|
1971-10-28 |
1974-06-05 |
Ici Ltd |
Process for the manufacture of 1,1,2-triphenylalk-1-enes
|
|
US4005063A
(en)
|
1973-10-11 |
1977-01-25 |
Abbott Laboratories |
[Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
|
|
GB1524747A
(en)
|
1976-05-11 |
1978-09-13 |
Ici Ltd |
Polypeptide
|
|
US4282361A
(en)
*
|
1978-03-16 |
1981-08-04 |
Massachusetts Institute Of Technology |
Synthesis for 7-alkylamino-3-methylpyrazolo [4,3-d]pyrimidines
|
|
DE2845574A1
(de)
|
1978-10-19 |
1980-04-24 |
Deutsches Krebsforsch |
Durch heterocyclische ringe oder alkylreste substituierte analoga von ccnu und verfahren zu deren herstellung
|
|
LU88769I2
(fr)
|
1982-07-23 |
1996-11-05 |
Zeneca Ltd |
Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
US4978672A
(en)
|
1986-03-07 |
1990-12-18 |
Ciba-Geigy Corporation |
Alpha-heterocyclc substituted tolunitriles
|
|
JPS6425763A
(en)
|
1987-04-24 |
1989-01-27 |
Mitsubishi Chem Ind |
Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
|
|
US5164196A
(en)
|
1987-05-19 |
1992-11-17 |
Ventech Research, Inc. |
Crotoxin complex as cytotoxic agent
|
|
EP0308020A3
(en)
|
1987-09-18 |
1990-12-05 |
Merck & Co. Inc. |
5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof
|
|
US5002755A
(en)
|
1988-02-18 |
1991-03-26 |
Vanderbilt University |
Method of controlling nephrotoxicity of anti-tumor plaintum compounds
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
AU7885991A
(en)
|
1990-05-26 |
1991-12-31 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
1,4-dihydropyridines for application in combatting resistance to drugs
|
|
FR2665898B1
(fr)
|
1990-08-20 |
1994-03-11 |
Sanofi |
Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
IL100110A0
(en)
|
1990-12-26 |
1992-08-18 |
American Cyanamid Co |
Insecticidal and synergistic miticidal compositions
|
|
SK44894A3
(en)
|
1991-10-18 |
1995-04-12 |
Monsanto Co |
Trisubstituted aromatic compounds, method of their preparation and fungicidal agents
|
|
DE69303494T2
(de)
|
1992-11-13 |
1997-01-16 |
Idec Pharma Corp |
Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
|
|
JP2862374B2
(ja)
|
1992-12-17 |
1999-03-03 |
フアイザー・インコーポレイテツド |
Ｃｒｆアンタゴニスト活性を有するピラゾール及びピラゾロピリミジン
|
|
JP3156026B2
(ja)
|
1993-12-27 |
2001-04-16 |
株式会社大塚製薬工場 |
ホスホン酸ジエステル誘導体
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
WO1996014843A2
(en)
|
1994-11-10 |
1996-05-23 |
Cor Therapeutics, Inc. |
Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
|
|
US5502068A
(en)
|
1995-01-31 |
1996-03-26 |
Synphar Laboratories, Inc. |
Cyclopropylpyrroloindole-oligopeptide anticancer agents
|
|
GB9514380D0
(en)
|
1995-07-13 |
1995-09-13 |
Knoll Ag |
Therapeutic agents
|
|
US5882864A
(en)
|
1995-07-31 |
1999-03-16 |
Urocor Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
US6218529B1
(en)
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
|
US5675024A
(en)
|
1995-11-22 |
1997-10-07 |
Allergan |
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
|
|
US5663357A
(en)
|
1995-11-22 |
1997-09-02 |
Allergan |
Substituted heteroarylamides having retinoid-like biological activity
|
|
WO1997027852A1
(en)
*
|
1996-01-30 |
1997-08-07 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU714851B2
(en)
|
1996-04-03 |
2000-01-13 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036881A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
EP0904076A1
(en)
|
1996-04-03 |
1999-03-31 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
JP2000511883A
(ja)
|
1996-04-19 |
2000-09-12 |
ノボ ノルディスク アクティーゼルスカブ |
ホスホチロシン認識ユニットを有する分子のモジュレーター
|
|
BR9708911A
(pt)
|
1996-05-03 |
1999-08-03 |
Abbott Lab |
Composto fragmento de peptídeo processo par tratar uma doença em um paciente em necessidade de terapia antioangiogênese composição polinucleotídeo único ou de duplo-filamento isolado vetor e processo para produzir um fragmento de peptídeo de kringle 5 ou proteína de fusão de kringle 5 solúvel
|
|
JP2000511558A
(ja)
|
1996-06-21 |
2000-09-05 |
アラーガン・セイルズ・インコーポレイテッド |
レチノイドおよび／またはレチノイド拮抗剤様生物学的活性を有する置換テトラヒドロナフタレンおよびジヒドロナフタレン誘導体
|
|
US6268308B1
(en)
|
1996-08-27 |
2001-07-31 |
Syngenta Crop Protection, Inc. |
Herbicidal S-substituted 1,2,4,6-thiatriazines
|
|
TW523506B
(en)
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
|
CZ225699A3
(cs)
|
1996-12-23 |
2000-09-13 |
Du Pont Pharmaceuticals Company |
Dusíkaté heteroaromatické sloučeniny jako inhibitory faktoru Xa
|
|
US6020357A
(en)
|
1996-12-23 |
2000-02-01 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
CZ299633B6
(cs)
*
|
1997-04-25 |
2008-09-24 |
Pfizer Inc. |
Pyrazolopyrimidinony, meziprodukty pro jejich výrobu a farmaceutické a veterinární kompozice na jejich bázi
|
|
CA2288787A1
(en)
*
|
1997-05-22 |
1998-11-26 |
G.D. Searle And Co. |
Pyrazole derivatives as p38 kinase inhibitors
|
|
HUP0003906A2
(hu)
|
1997-06-19 |
2001-05-28 |
Du Pont Pharmaceuticals Co. |
Xa faktort gátló hatású heterociklusos vegyületek és ezeket tartalmazó gyógyszerkészítmények
|
|
ES2267873T3
(es)
|
1997-10-27 |
2007-03-16 |
Agouron Pharmaceuticals, Inc. |
Derivados de 4-aminotiazol, su preparacion y uso como inhibidores de kinasas dependientes de ciclina.
|
|
ATE260103T1
(de)
|
1997-12-19 |
2004-03-15 |
Schering Ag |
Ortho-anthranilamide derivate als antikoagulantien
|
|
CA2314401A1
(en)
|
1997-12-22 |
1999-07-01 |
Du Pont Pharmaceuticals Company |
Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
|
|
WO1999067235A1
(en)
|
1998-06-25 |
1999-12-29 |
Sumitomo Pharmaceuticals Co., Ltd. |
Five-membered ring compounds
|
|
WO2000006169A1
(en)
|
1998-07-29 |
2000-02-10 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
|
JP2000186092A
(ja)
|
1998-12-22 |
2000-07-04 |
Kyowa Hakko Kogyo Co Ltd |
Ｕｃｎ−０１の製造法
|
|
WO2000038683A1
(en)
|
1998-12-23 |
2000-07-06 |
Du Pont Pharmaceuticals Company |
THROMBIN OR FACTOR Xa INHIBITORS
|
|
AU4327600A
(en)
|
1999-04-02 |
2000-10-23 |
Du Pont Pharmaceuticals Company |
Aryl sulfonyls as factor xa inhibitors
|
|
CN1348370A
(zh)
|
1999-04-15 |
2002-05-08 |
布里斯托尔-迈尔斯斯奎布公司 |
环状蛋白酪氨酸激酶抑制剂
|
|
US6166244A
(en)
|
1999-05-07 |
2000-12-26 |
Allergan Sales, Inc. |
Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
|
|
EP1185512A2
(en)
|
1999-05-24 |
2002-03-13 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
FR2795726A1
(fr)
|
1999-06-30 |
2001-01-05 |
Aventis Cropscience Sa |
Nouveaux pyrazoles fongicides
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
US6093838A
(en)
|
1999-08-16 |
2000-07-25 |
Allergan Sales, Inc. |
Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
US6127382A
(en)
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
AU6936500A
(en)
|
1999-08-24 |
2001-03-19 |
Regents Of The University Of California, The |
Non-quinoline inhibitors of malaria parasites
|
|
HUP0203954A2
(hu)
|
1999-09-17 |
2003-03-28 |
Millennium Pharmaceuticals, Inc. |
Xa faktor inhibitorok
|
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
BR0014076A
(pt)
|
1999-09-17 |
2002-10-15 |
Millennium Pharm Inc |
Benzamidas e inibidores correlatos do fator xa
|
|
EP1228043B1
(en)
|
1999-11-05 |
2005-01-12 |
SmithKline Beecham plc |
Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
EP1259887A4
(en)
|
2000-01-25 |
2003-08-13 |
Vistaprint Usa Inc |
Managing print jobs
|
|
BR0104424A
(pt)
|
2000-02-05 |
2002-01-08 |
Vertex Pharma |
Composições de pirazol úteis como inibidores de erk
|
|
EP1254115A2
(en)
|
2000-02-11 |
2002-11-06 |
Bristol-Myers Squibb Company |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
|
|
DK1259485T3
(da)
|
2000-02-29 |
2006-04-10 |
Millennium Pharm Inc |
Benzamider og beslægtede inhibitorer for faktor Xa
|
|
WO2001068585A1
(en)
*
|
2000-03-14 |
2001-09-20 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel amide compounds
|
|
MY138097A
(en)
|
2000-03-22 |
2009-04-30 |
Du Pont |
Insecticidal anthranilamides
|
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
AU4262901A
(en)
|
2000-03-29 |
2001-10-08 |
Cyclacel Ltd |
2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders
|
|
BR0110302A
(pt)
*
|
2000-04-18 |
2003-01-14 |
Agouron Pharma |
Compostos de pirazol para inibição de proteìnas cinase, sal e pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo ou sal farmaceuticamente aceitável de metabólito, composição farmacêutica, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase, método de modulação ou inibição da atividade de um receptor de proteìna cinase
|
|
AU4878601A
(en)
|
2000-04-20 |
2001-11-07 |
Mitsubishi Corporation |
Aromatic amide compounds
|
|
JP2004507455A
(ja)
|
2000-04-25 |
2004-03-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
サイクリン依存性キナーゼ阻害剤としての、５−チオ−、スルフィニル−およびスルホニルピラゾロ［３，４−ｂ］−ピリジンの用途
|
|
MXPA02010608A
(es)
|
2000-04-27 |
2003-05-14 |
Abbott Lab |
Inhibidores de farnesiltransferasa sustituidos con fenilo.
|
|
US6414013B1
(en)
|
2000-06-19 |
2002-07-02 |
Pharmacia & Upjohn S.P.A. |
Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
|
|
WO2002000651A2
(en)
|
2000-06-27 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Factor xa inhibitors
|
|
IL153645A0
(en)
|
2000-07-31 |
2003-07-06 |
Smithkline Beecham Plc |
Carboxamide compounds and their use as antagonists of a human 11cby receptor
|
|
SK2002003A3
(en)
*
|
2000-08-31 |
2004-04-06 |
Pfizer Prod Inc |
Pyrazole derivatives and their use as protein kinase inhibitors
|
|
ATE346064T1
(de)
|
2000-09-15 |
2006-12-15 |
Vertex Pharma |
Pyrazolverbindungen als protein-kinasehemmer
|
|
CA2420164A1
(en)
|
2000-10-20 |
2002-05-02 |
Bristol-Myers Squibb Pharma Company |
Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors
|
|
US6455559B1
(en)
*
|
2001-07-19 |
2002-09-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
|
ATE354573T1
(de)
|
2000-12-21 |
2007-03-15 |
Vertex Pharma |
ßPYRAZOLVERBINDUNGEN, DIE SICH ALS PROTEINKINASEINHIBITOREN EIGNENß
|
|
DE10064823A1
(de)
|
2000-12-22 |
2002-06-27 |
Knoll Ag |
Integrinrezeptorliganden
|
|
US7105682B2
(en)
*
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US6995162B2
(en)
*
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US6878714B2
(en)
|
2001-01-12 |
2005-04-12 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
GB0102687D0
(en)
*
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
|
CN1492758A
(zh)
|
2001-02-28 |
2004-04-28 |
C���ֶ� |
抗肿瘤和抗转移作用的方法和制剂
|
|
WO2002070483A1
(en)
|
2001-03-05 |
2002-09-12 |
E. I. Du Pont De Nemours And Company |
Heterocyclic diamide invertebrate pest control agents
|
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
MXPA03006310A
(es)
*
|
2001-03-16 |
2003-09-16 |
Pfizer |
Compuestos farmaceuticamente activos.
|
|
GB0106661D0
(en)
*
|
2001-03-16 |
2001-05-09 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
WO2002074298A1
(en)
*
|
2001-03-21 |
2002-09-26 |
Ono Pharmaceutical Co., Ltd. |
Il-6 production inhibitors
|
|
CA2444031C
(en)
|
2001-04-16 |
2012-02-21 |
Schering Corporation |
3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
|
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
|
JP2005503131A
(ja)
|
2001-05-11 |
2005-02-03 |
ザ バーナム インスティチュート |
Ｒｉｚに関するスクリーニング、診断および治療の方法
|
|
WO2002094183A2
(en)
|
2001-05-18 |
2002-11-28 |
Tap Pharmaceutical Products Inc. |
A method for tumor treatment with fumagillol derivatives
|
|
KR100849815B1
(ko)
|
2001-05-21 |
2008-07-31 |
이 아이 듀폰 디 네모아 앤드 캄파니 |
비방향족 헤테로시클릭 고리를 포함하는 디아미드 무척추해충 방제제
|
|
WO2002101007A2
(en)
|
2001-06-13 |
2002-12-19 |
Genesoft Pharmaceuticals, Inc |
Antipathogenic benzamide compounds
|
|
WO2003011287A1
(en)
|
2001-08-03 |
2003-02-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazolon derivatives as inhibitors of gsk-3
|
|
EP1423380B1
(en)
|
2001-08-03 |
2010-12-15 |
Vertex Pharmaceuticals Incorporated |
Pyrazole-derived kinase inhibitors and uses thereof
|
|
US20030078232A1
(en)
|
2001-08-08 |
2003-04-24 |
Elfatih Elzein |
Adenosine receptor A3 agonists
|
|
AUPR738301A0
(en)
|
2001-08-30 |
2001-09-20 |
Starpharma Limited |
Chemotherapeutic agents
|
|
CA2457922A1
(en)
|
2001-08-31 |
2003-03-13 |
University Of Connecticut |
Novel pyrazole analogs acting on cannabinoid receptors
|
|
MXPA04002397A
(es)
|
2001-09-14 |
2004-12-02 |
Methylgene Inc |
Inhibidores de histona deacetilasa.
|
|
CN1599734A
(zh)
|
2001-10-12 |
2005-03-23 |
先灵公司 |
作为cxc趋化因子受体拮抗剂的3,4－二取代的马来酰亚胺化合物
|
|
HN2002000317A
(es)
*
|
2001-11-02 |
2003-05-21 |
Pfizer |
Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
|
|
EP1442041A1
(en)
|
2001-11-08 |
2004-08-04 |
PHARMACIA & UPJOHN COMPANY |
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
|
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
US20030166932A1
(en)
|
2002-01-04 |
2003-09-04 |
Beard Richard L. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
GEP20063909B
(en)
|
2002-01-22 |
2006-08-25 |
Warner Lambert Co |
2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d] PYRIMIDIN-7-ONES
|
|
US7205307B2
(en)
|
2002-02-14 |
2007-04-17 |
Icagen, Inc. |
Pyrimidines as novel openers of potassium ion channels
|
|
MXPA04008577A
(es)
|
2002-03-04 |
2005-07-13 |
Aton Pharma Inc |
Metodos para inducir diferenciacion terminal.
|
|
WO2003077918A1
(en)
|
2002-03-12 |
2003-09-25 |
Merck & Co., Inc. |
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
|
DE60237425D1
(de)
|
2002-03-28 |
2010-10-07 |
Univerzita Palackeho V Olomouc |
PyrazoloÄ4,3-dÜpyrimidine, Verfahren zu ihrer Herstellung und therapeutische Anwendung
|
|
US6995168B2
(en)
|
2002-05-31 |
2006-02-07 |
Euro-Celtique S.A. |
Triazaspiro compounds useful for treating or preventing pain
|
|
AU2003249369A1
(en)
|
2002-06-21 |
2004-01-06 |
Cellular Genomics, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
|
DE60326735D1
(de)
|
2002-08-02 |
2009-04-30 |
Genesoft Pharmaceuticals Inc |
Biaryl-verbindungen mit antiinfektiver wirkung
|
|
GB0218625D0
(en)
|
2002-08-10 |
2002-09-18 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
JP4845379B2
(ja)
|
2002-09-19 |
2011-12-28 |
シェーリング コーポレイション |
サイクリン依存性キナーゼインヒビターとしてのイミダゾピリジン
|
|
US6737382B1
(en)
|
2002-10-23 |
2004-05-18 |
Nippon Soda Co. Ltd. |
Insecticidal aminothiazole derivatives
|
|
WO2004039795A2
(en)
|
2002-10-29 |
2004-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds for the treatment of hyperlipidemia
|
|
US20050026877A1
(en)
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
KR101076018B1
(ko)
|
2003-01-08 |
2011-10-21 |
유니버시티 오브 워싱톤 |
항균제
|
|
US7169797B2
(en)
*
|
2003-02-14 |
2007-01-30 |
Abbott Laboratories |
Protein-tyrosine phosphatase inhibitors and uses thereof
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
AR043633A1
(es)
|
2003-03-20 |
2005-08-03 |
Schering Corp |
Ligandos de receptores de canabinoides
|
|
WO2004098518A2
(en)
|
2003-05-01 |
2004-11-18 |
Bristol-Myers Squibb Company |
Pyrazole-amide compounds useful as kinase inhibitors
|
|
WO2004099127A1
(en)
|
2003-05-07 |
2004-11-18 |
Novo Nordisk A/S |
Novel compounds as kinase inhibitors
|
|
EP1625115A1
(en)
|
2003-05-09 |
2006-02-15 |
Pharmacia & Upjohn Company LLC |
Substituted pyrimidine derivatives
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
JPWO2005000356A1
(ja)
|
2003-06-27 |
2006-08-03 |
小野薬品工業株式会社 |
尿路疾患治療剤
|
|
TWI372050B
(en)
*
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
BRPI0412259B1
(pt)
|
2003-07-22 |
2019-08-20 |
Astex Therapeutics Limited |
Compostos de 1H-pirazol 3,4-dissubstituídos como moduladores de quinases dependentes de ciclina (CDK), seus usos, processo para a preparação dos mesmos e composição farmacêutica
|
|
SE0303396D0
(sv)
|
2003-12-16 |
2003-12-16 |
Astrazeneca Ab |
Chemical compounds
|
|
CN1960731B
(zh)
|
2004-02-20 |
2011-12-07 |
诺华疫苗和诊断公司 |
调节炎性和转移过程的方法
|
|
ES2430371T3
(es)
|
2004-03-11 |
2013-11-20 |
4Sc Ag |
Sulfonilpirroles como inhibidores de HDAC
|
|
US20060084691A1
(en)
|
2004-10-18 |
2006-04-20 |
Bilal Piperdi |
Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
|
|
US20080139620A1
(en)
*
|
2005-01-21 |
2008-06-12 |
Astex Therapeutics Limited |
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's
|
|
KR101345002B1
(ko)
|
2005-01-21 |
2013-12-31 |
아스텍스 테라퓨틱스 리미티드 |
제약 화합물
|
|
CA2594477C
(en)
*
|
2005-01-21 |
2016-07-12 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
WO2008007113A2
(en)
|
2006-07-14 |
2008-01-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
AR052660A1
(es)
|
2005-01-21 |
2007-03-28 |
Astex Therapeutics Ltd |
Derivados de pirazol para inhibir la cdk's y gsk's
|
|
US20080161355A1
(en)
*
|
2005-01-21 |
2008-07-03 |
Astex Therapeutics Limited |
Combinations of Pyrazole Kinase Inhibitors and Further Antitumor Agents
|
|
AU2007246895A1
(en)
|
2006-05-05 |
2007-11-15 |
Astex Therapeutics Limited |
4- (2,6-dichloro-benzoylamino) -1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
|
|
WO2007129062A1
(en)
|
2006-05-08 |
2007-11-15 |
Astex Therapeutics Limited |
Pharmaceutical combinations of diazole derivatives for cancer treatment
|
|
WO2008001101A2
(en)
|
2006-06-29 |
2008-01-03 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
WO2008007122A2
(en)
|
2006-07-14 |
2008-01-17 |
Astex Therapeutics Limited |
Combinations of pyrazole derivatives for the inhibition of cdks and gsk's
|
|
EP2049516A2
(en)
|
2006-07-14 |
2009-04-22 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
EP2046327A1
(en)
|
2006-07-21 |
2009-04-15 |
Astex Therapeutics Limited |
Medical use of cyclin dependent kinases inhibitors
|
|
EP2073803B1
(en)
|
2006-10-12 |
2018-09-19 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|